BG100531A - Method for inhibition of photodecomposition of 3-substituted 2-oxindoles - Google Patents

Method for inhibition of photodecomposition of 3-substituted 2-oxindoles

Info

Publication number
BG100531A
BG100531A BG100531A BG10053196A BG100531A BG 100531 A BG100531 A BG 100531A BG 100531 A BG100531 A BG 100531A BG 10053196 A BG10053196 A BG 10053196A BG 100531 A BG100531 A BG 100531A
Authority
BG
Bulgaria
Prior art keywords
substituted
photodecomposition
inhibition
oxindoles
oxindole
Prior art date
Application number
BG100531A
Other languages
Bulgarian (bg)
English (en)
Inventor
Willard Newlin
Sharon Laughlin
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of BG100531A publication Critical patent/BG100531A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Polymerisation Methods In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG100531A 1995-04-24 1996-04-23 Method for inhibition of photodecomposition of 3-substituted 2-oxindoles BG100531A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (1)

Publication Number Publication Date
BG100531A true BG100531A (en) 1997-06-30

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100531A BG100531A (en) 1995-04-24 1996-04-23 Method for inhibition of photodecomposition of 3-substituted 2-oxindoles

Country Status (30)

Country Link
EP (1) EP0827399A1 (sv)
JP (1) JPH10506635A (sv)
KR (1) KR100189585B1 (sv)
CN (1) CN1053667C (sv)
AP (1) AP607A (sv)
AR (1) AR002728A1 (sv)
AU (1) AU692378B2 (sv)
BG (1) BG100531A (sv)
BR (1) BR9602024A (sv)
CO (1) CO4700418A1 (sv)
FI (1) FI973988A (sv)
HR (1) HRP960194A2 (sv)
HU (1) HU216544B (sv)
IL (1) IL117969A0 (sv)
IS (1) IS4339A (sv)
MA (1) MA23848A1 (sv)
NO (1) NO961622L (sv)
NZ (1) NZ286432A (sv)
OA (1) OA10286A (sv)
PE (1) PE34397A1 (sv)
RO (1) RO113305B1 (sv)
RU (1) RU2109510C1 (sv)
SG (1) SG64924A1 (sv)
SI (1) SI9600133A (sv)
SK (1) SK51296A3 (sv)
TR (1) TR199600300A2 (sv)
UA (1) UA42739C2 (sv)
WO (1) WO1996033701A1 (sv)
YU (1) YU25096A (sv)
ZA (1) ZA963210B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111526730B (zh) 2017-12-29 2024-02-23 卡夫食品集团品牌有限责任公司 使用天然稳定剂改善的水包油乳液的氧化稳定性

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
FI973988A0 (sv) 1997-10-17
AP9600787A0 (en) 1996-04-30
YU25096A (sh) 1998-08-14
AU5085196A (en) 1996-11-07
AP607A (en) 1997-08-27
RU2109510C1 (ru) 1998-04-27
CN1139110A (zh) 1997-01-01
EP0827399A1 (en) 1998-03-11
UA42739C2 (uk) 2001-11-15
IS4339A (is) 1996-10-25
TR199600300A2 (tr) 1996-11-21
FI973988A (sv) 1997-10-17
IL117969A0 (en) 1996-08-04
PE34397A1 (es) 1997-09-29
SI9600133A (en) 1996-10-31
CO4700418A1 (es) 1998-12-29
HU9601057D0 (en) 1996-06-28
OA10286A (en) 1997-09-19
AR002728A1 (es) 1998-04-29
CN1053667C (zh) 2000-06-21
HUP9601057A3 (en) 1997-05-28
KR100189585B1 (ko) 1999-06-01
KR960037656A (ko) 1996-11-19
HU216544B (hu) 1999-07-28
NZ286432A (en) 1998-05-27
ZA963210B (en) 1997-10-23
SK51296A3 (en) 1997-04-09
RO113305B1 (ro) 1998-06-30
NO961622D0 (no) 1996-04-23
HRP960194A2 (en) 1998-02-28
JPH10506635A (ja) 1998-06-30
NO961622L (no) 1996-10-25
MA23848A1 (fr) 1996-12-31
HUP9601057A2 (en) 1997-04-28
WO1996033701A1 (en) 1996-10-31
BR9602024A (pt) 1998-10-06
AU692378B2 (en) 1998-06-04
SG64924A1 (en) 1999-05-25

Similar Documents

Publication Publication Date Title
TW350844B (en) Tricyclic amides useful to inhibition of G-protein function and for treatment of proliferative diseases
MX9800804A (es) Derivados de pirrolidina que tienen actividad inhibitoria de la fosfolipasa a2.
MY117896A (en) Quinazoline derivatives
BG101833A (en) Guanine derivative
YU69902A (sh) Novi derivati piperazina
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
EP0807633A3 (en) Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
DK1302207T3 (da) Fremgangsmåde til at fremstille et antihypertensivt middel indeholdende et dipeptid som virkningsfuld bestanddel
MX9706605A (es) Derivados de indol como antagonistas de los aminoacidos exitadores.
UA41353C2 (uk) Похідні алкілбензоїлгуанідинів, спосіб їх одержання, фармацевтична композиція, що має аритмічну активність
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
NO975921L (no) Fremstilling av bicykloheksanderivater
ES2104509A1 (es) Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
BG100531A (en) Method for inhibition of photodecomposition of 3-substituted 2-oxindoles
FI973644A0 (sv) Nytt förfarande för framställning av 2,3-dihydrobenzofuranolderivat
PT855398E (pt) Derivados sasquiterpeno tendo actividade antiviral
IL124353A0 (en) Production of a salt of clavulanic acid
BG103986A (en) Derivatives of pyrrolidinecarboxylic acids as endotheline antagonists
FI972389A0 (sv) Nytt förfarande för framställning av ranitidin
DE69410159D1 (de) Neue Verbindung, Leustroducsin H, ihre Herstellung und therapeutische Verwendung
ES8704163A1 (es) Un procedimiento para preparar derivados de cefem.
AU7503496A (en) Stable, long acting salts of indole derivatives for the treatment of joint diseases
MX9701220A (es) Antagonistas de endotelina.